A detailed history of E&G Advisors, LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, E&G Advisors, LP holds 5,451 shares of BMY stock, worth $287,049. This represents 0.08% of its overall portfolio holdings.

Number of Shares
5,451
Previous 5,851 6.84%
Holding current value
$287,049
Previous $242,000 16.53%
% of portfolio
0.08%
Previous 0.07%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$39.66 - $51.75 $15,863 - $20,700
-400 Reduced 6.84%
5,451 $282,000
Q2 2024

Jul 18, 2024

BUY
$40.25 - $52.99 $12,075 - $15,897
300 Added 5.4%
5,851 $242,000
Q1 2024

Apr 19, 2024

BUY
$47.98 - $54.4 $14,441 - $16,374
301 Added 5.73%
5,551 $301,000
Q4 2023

Jan 25, 2024

SELL
$48.48 - $57.85 $29,087 - $34,710
-600 Reduced 10.26%
5,250 $269,000
Q3 2023

Oct 25, 2023

SELL
$57.89 - $64.73 $2,894 - $3,236
-50 Reduced 0.85%
5,850 $339,000
Q1 2023

Jul 20, 2023

SELL
$65.71 - $74.53 $46,325 - $52,543
-705 Reduced 10.67%
5,900 $408,000
Q1 2023

Apr 17, 2023

BUY
$65.71 - $74.53 $52,896 - $59,996
805 Added 13.88%
6,605 $457,000
Q4 2022

Jan 13, 2023

BUY
$68.48 - $81.09 $13,696 - $16,218
200 Added 3.57%
5,800 $0
Q3 2022

Oct 11, 2022

SELL
$0.13 - $76.84 $9 - $5,378
-70 Reduced 1.23%
5,600 $398,000
Q2 2022

Jul 06, 2022

SELL
$72.62 - $79.98 $2,178 - $2,399
-30 Reduced 0.53%
5,670 $437,000
Q1 2022

Apr 12, 2022

SELL
$61.48 - $73.72 $49,184 - $58,976
-800 Reduced 12.31%
5,700 $416,000
Q3 2021

Oct 20, 2021

BUY
$59.17 - $69.31 $384,605 - $450,515
6,500 New
6,500 $385,000
Q2 2021

Jul 12, 2021

SELL
$61.91 - $67.42 $414,797 - $451,714
-6,700 Closed
0 $448,000
Q1 2020

Apr 08, 2020

BUY
$46.4 - $67.43 $37,120 - $53,944
800 Added 13.56%
6,700 $373,000
Q4 2019

Jan 10, 2020

SELL
$49.21 - $64.19 $98,420 - $128,380
-2,000 Reduced 25.32%
5,900 $379,000
Q3 2019

Oct 10, 2019

SELL
$42.77 - $50.71 $8,554 - $10,142
-200 Reduced 2.47%
7,900 $401,000
Q2 2019

Jul 12, 2019

BUY
$44.62 - $49.34 $26,772 - $29,604
600 Added 8.0%
8,100 $367,000
Q1 2019

Apr 18, 2019

SELL
$45.12 - $53.8 $148,896 - $177,540
-3,300 Reduced 30.56%
7,500 $358,000
Q4 2018

Jan 17, 2019

BUY
$48.76 - $63.23 $53,636 - $69,553
1,100 Added 11.34%
10,800 $561,000
Q3 2018

Oct 10, 2018

BUY
$55.19 - $62.25 $104,861 - $118,275
1,900 Added 24.36%
9,700 $602,000
Q2 2018

Jul 30, 2018

BUY
$50.53 - $62.98 $35,371 - $44,086
700 Added 9.86%
7,800 $432,000
Q1 2018

Apr 18, 2018

SELL
$59.92 - $68.98 $42,902 - $49,389
-716 Reduced 9.16%
7,100 $449,000
Q4 2017

Jan 16, 2018

BUY
$59.94 - $65.35 $89,910 - $98,024
1,500 Added 23.75%
7,816 $479,000
Q3 2017

Oct 20, 2017

BUY
$55.23 - $63.74 $348,832 - $402,581
6,316
6,316 $403,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $112B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track E&G Advisors, LP Portfolio

Follow E&G Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E&G Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on E&G Advisors, LP with notifications on news.